Organizational Overview:

Immunovant, Inc. is a clinical-stage biopharmaceutical company dedicated to enabling normal lives for people with autoimmune diseases. As a leader in FcRn inhibitor technology, we are boldly developing innovative therapies for a range of debilitating autoimmune diseases with significant unmet patient needs. Our investigational compound, batoclimab, is a novel, fully human, monoclonal antibody targeting the neonatal Fc receptor (FcRn). Optimized as a subcutaneous injection with flexibility in dosing and approach, batoclimab is designed to reduce immunoglobin G (IgG) antibodies that cause inflammation and disease.

The Role:

The Senior Director, Medical Writing prepares and reviews clinical/regulatory documents to support all phases of drug development by leading the writing activities of an interdisciplinary team to develop documents that are strategic, high quality, and comply with internal and external standards. This role is responsible for the complete preparation, including but not limited to, the writing, reviewing, editing, and finalization of protocols and protocol amendments, Investigator’s Brochures (IBs) and IB updates, clinical study reports (CSRs), Summary Modules for Regulatory Submissions, regulatory agency briefing documents, and regulatory agency responses.

The Senior Director, Medical Writing will lead the writing activities for all clinical and regulatory documents for the program, which include leading and managing the writing process, managing and driving timelines for multiple parallel documents, and ensuring documents are quality-checked.  This individual will develop strong collaborative working relationships with cross-functional team members. As a content expert, this position has a significant understanding of regulatory requirements and ICH guidelines (including E3 and E6), and knowledge of electronic document formats and document management systems.  The Senior Director, Medical Writing will collaborate with the Head of Medical Communications to align core concepts and strategic messaging between clinical/regulatory documents and medical communications such as publications/posters/abstracts. 

Key Responsibilities: 

  • Authoring, facilitating review cycles, finalization of submission-ready documents compliant with regulations and aligned with core messages
  • Manage timelines and cross-functional relationships
  • Interpret complex data for communication


  • Minimum 5 years of medical writing experience in pharma/biotech with a Master’s of Science degree, PharmD, PhD, or MD preferred;
  • Minimum 7 years of medical writing experience in pharma/biotech with a Bachelor's degree in Life Sciences.
  • Experience authoring successful global clinical and regulatory documents, such as clinical protocols and amendments, clinical study reports, investigator’s brochures, regulatory agency meeting briefing documents, regulatory agency responses, NDA/BLA/MAA summary sections, white papers
  • Strong science background that enables the ability to independently interpret and present scientific and clinical data, and to understand statistical methods and analysis plans
  • Clear understanding of clinical development, including the phases, processes, and techniques used within a clinical development environment from protocol design through regulatory submissions.
  • Understanding of FDA/international regulations, ICH guidelines, and applicable US/international regulatory processes related to document preparation and production (including CTDs and electronic submission-ready documents).
  • Proven ability to lead cross-functional teams through the authoring, reviewing, and finalization process and meet timelines
  • Strong communication and interpersonal skills and the ability to negotiate and influence in a cross-functional environment to achieve results
  • Excellent team player who can effectively collaborate with varied opinions and personalities
  • Able to work well both independently and as part of a team
  • Excellent organizational and project management skills, including managing simultaneous projects in a fast-paced environment
  • Familiar with style rules from the American Association Manual of Style and stays current with changes and expectations in templates and document formats
  • Excellent understanding of Microsoft Word and Powerpoint, document management systems, and electronic review tools
  • Immunology or biologics experience preferred
  • Experience with neurology, rare diseases preferred
  • Experience with orphan drug designations, other regulatory designations, PSP/PIPs a plus
  • Commitment to company values and culture
  • Proven ability to adapt to change and uncertainty as projects evolve
  • Strong oral and written communicator
  • Self-motivated, with initiative and the ability to take ownership of, and follow through with, specific tasks.
  • Ability to multi-task and adjust priorities quickly while working under tight deadlines.
  • Skilled in developing collaborative internal and external relationships.
  • Strong PC experience and demonstrated proficiency in MS Office (Outlook, Word, Excel, PowerPoint)

Work Environment:

  • Immunovant’s headquarters is located in New York City. The position is flexible for remote work
  • Dynamic, interactive, fast-paced, and entrepreneurial environment
  • May need to travel to NYC office or Durham office as needed

Apply for this Job

* Required

Voluntary Self-Identification

For government reporting purposes, we ask candidates to respond to the below self-identification survey. Completion of the form is entirely voluntary. Whatever your decision, it will not be considered in the hiring process or thereafter. Any information that you do provide will be recorded and maintained in a confidential file.

As set forth in IMVT Corporation’s Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law.

Race & Ethnicity Definitions

If you believe you belong to any of the categories of protected veterans listed below, please indicate by making the appropriate selection. As a government contractor subject to the Vietnam Era Veterans Readjustment Assistance Act (VEVRAA), we request this information in order to measure the effectiveness of the outreach and positive recruitment efforts we undertake pursuant to VEVRAA. Classification of protected categories is as follows:

A "disabled veteran" is one of the following: a veteran of the U.S. military, ground, naval or air service who is entitled to compensation (or who but for the receipt of military retired pay would be entitled to compensation) under laws administered by the Secretary of Veterans Affairs; or a person who was discharged or released from active duty because of a service-connected disability.

A "recently separated veteran" means any veteran during the three-year period beginning on the date of such veteran's discharge or release from active duty in the U.S. military, ground, naval, or air service.

An "active duty wartime or campaign badge veteran" means a veteran who served on active duty in the U.S. military, ground, naval or air service during a war, or in a campaign or expedition for which a campaign badge has been authorized under the laws administered by the Department of Defense.

An "Armed forces service medal veteran" means a veteran who, while serving on active duty in the U.S. military, ground, naval or air service, participated in a United States military operation for which an Armed Forces service medal was awarded pursuant to Executive Order 12985.

Form CC-305

OMB Control Number 1250-0005

Expires 05/31/2023

Voluntary Self-Identification of Disability

Why are you being asked to complete this form?

We are a federal contractor or subcontractor required by law to provide equal employment opportunity to qualified people with disabilities. We are also required to measure our progress toward having at least 7% of our workforce be individuals with disabilities. To do this, we must ask applicants and employees if they have a disability or have ever had a disability. Because a person may become disabled at any time, we ask all of our employees to update their information at least every five years.

Identifying yourself as an individual with a disability is voluntary, and we hope that you will choose to do so. Your answer will be maintained confidentially and not be seen by selecting officials or anyone else involved in making personnel decisions. Completing the form will not negatively impact you in any way, regardless of whether you have self-identified in the past. For more information about this form or the equal employment obligations of federal contractors under Section 503 of the Rehabilitation Act, visit the U.S. Department of Labor’s Office of Federal Contract Compliance Programs (OFCCP) website at

How do you know if you have a disability?

You are considered to have a disability if you have a physical or mental impairment or medical condition that substantially limits a major life activity, or if you have a history or record of such an impairment or medical condition.

Disabilities include, but are not limited to:

  • Autism
  • Autoimmune disorder, for example, lupus, fibromyalgia, rheumatoid arthritis, or HIV/AIDS
  • Blind or low vision
  • Cancer
  • Cardiovascular or heart disease
  • Celiac disease
  • Cerebral palsy
  • Deaf or hard of hearing
  • Depression or anxiety
  • Diabetes
  • Epilepsy
  • Gastrointestinal disorders, for example, Crohn's Disease, or irritable bowel syndrome
  • Intellectual disability
  • Missing limbs or partially missing limbs
  • Nervous system condition for example, migraine headaches, Parkinson’s disease, or Multiple sclerosis (MS)
  • Psychiatric condition, for example, bipolar disorder, schizophrenia, PTSD, or major depression

1Section 503 of the Rehabilitation Act of 1973, as amended. For more information about this form or the equal employment obligations of Federal contractors, visit the U.S. Department of Labor's Office of Federal Contract Compliance Programs (OFCCP) website at

PUBLIC BURDEN STATEMENT: According to the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless such collection displays a valid OMB control number. This survey should take about 5 minutes to complete.